Increased risk of CNS depression; avoid concomitant use and monitor for adverse reactions.
Source: NLP:metoclopramide hydrochloride
14 interactions on record
Increased risk of CNS depression; avoid concomitant use and monitor for adverse reactions.
Source: NLP:metoclopramide hydrochloride
Other CNS depressants may enhance effects causing increased CNS depression.
Source: NLP:butalbital, acetaminophen, and caffeine
Butalbital causes increased CNS depression when combined with other CNS depressants.
Source: NLP:butalbital, aspirin, and caffeine
Potentiate sedating effects of clonidine. Avoid use.
Source: NLP:clonidine hydrochloride
Concomitant use increases risk of sedation and somnolence; effects may be potentiated.
Source: NLP:clobazam
Sedative effects of CNS depressants may be potentiated when taken with doxepin.
Source: NLP:doxepin
Sedative effects of CNS depressants may be potentiated when taken with doxepin.
Source: NLP:doxepin hydrochloride
Additive CNS effects (dizziness, confusion, sedation, somnolence) may occur when taken concomitantly with dronabinol.
Source: NLP:dronabinol
Haloperidol may potentiate CNS depressants including anesthetics, opioids, and alcohol.
Source: NLP:haloperidol decanoate
Concurrent use may result in increased CNS depression; monitor accordingly.
Source: NLP:meclizine hydrochloride
Concomitant use may increase risk of sedation and respiratory depression. Closely monitor for signs of respiratory depression and sedation, particularly during treatment initiation and dosage increases.
Source: NLP:metaxalone
Increased risk of sedation and respiratory depression with concomitant use. Closely monitor for adverse effects.
Source: NLP:phenobarbital sodium
Should be used with extreme caution due to potential CNS depression and cognitive/neuropsychiatric adverse reactions.
Source: NLP:topiramate
Triazolam produces additive CNS depressant effects when co-administered with other CNS depressants. Dosage and duration should be limited during concomitant use.
Source: NLP:triazolam